Collection
Summary of Research Articles
- Submission status
- Open
- Open for submission from
- 07 June 2023
- Submission deadline
- Ongoing
This collection contains Summary of Research Articles (SRAs) published in the journal. An SRA is a standalone summary of a source article previously published in an Adis journal, or in a journal from another publisher.
Articles (11 in this collection)
-
-
Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
Authors (first, second and last of 21)
- Masahiro Tsuboi
- Roy S. Herbst
- Yi-Long Wu
- Content type: Summary of Research
- Open Access
- Published: 11 March 2024
- Targeted Oncology
- Pages: 131 - 134
-
Summary of Research: What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation
Authors (first, second and last of 4)
- Sarah A. Morrow
- Paola Kruger
- Nektaria Alexandri
- Content type: SUMMARY OF RESEARCH
- Open Access
- Published: 20 February 2024
- Neurology and Therapy
- Pages: 497 - 499
-
Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study
Authors (first, second and last of 10)
- Emma Guttman-Yassky
- Eric L. Simpson
- Masutaka Furue
- Content type: Summary of Research
- Open Access
- Published: 08 January 2024
- Advances in Therapy
- Pages: 928 - 931
-
Summary of Research: Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial
Authors
- Alan Menter
- Content type: Summary of Research
- Open Access
- Published: 24 October 2023
- Dermatology and Therapy
- Pages: 2929 - 2932
-
Summary of Research: Adjuvant Nivolumab Plus Ipilimumab Versus Placebo for Localized Renal Cell Carcinoma After Nephrectomy (CheckMate 914): A Double-Blind, Randomized, Phase 3 Trial
Authors (first, second and last of 22)
- Robert J. Motzer
- Paul Russo
- Axel Bex
- Content type: Summary of research
- Open Access
- Published: 02 September 2023
- Targeted Oncology
- Pages: 639 - 641
-
Adis Summary of Research: Safety, Effectiveness, and Immunogenicity 6 Months After BNT162B2 mRNA Vaccine in Frail Nursing Home Residents
Authors
- Julia Paik
- Zaina T. Al-Salama
- Content type: Adis Summary of Research
- Published: 29 July 2023
- Drugs & Therapy Perspectives
- Pages: 317 - 318
-
Summary of Research: Terminal Complement Inhibitor Ravulizumab in Generalized Myasthenia Gravis
Authors (first, second and last of 10)
- Tuan Vu
- Andreas Meisel
- James F. Howard Jr.
- Content type: Summary of Research
- Open Access
- Published: 23 June 2023
- Neurology and Therapy
- Pages: 1435 - 1438
-
Summary of Research: Caregiver Involvement in MS: Duty or Disruption?
Authors (first, second and last of 6)
- Jürg Kesselring
- Alexey Boyko
- Nektaria Alexandri
- Content type: SUMMARY OF RESEARCH
- Open Access
- Published: 21 June 2023
- Neurology and Therapy
- Pages: 1431 - 1434
-
Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
Authors (first, second and last of 5)
- Stacie Hudgens
- Andrea Phillips-Beyer
- Heike Benes
- Content type: Summary of Research
- Open Access
- Published: 26 April 2023
- Advances in Therapy
- Pages: 2573 - 2576
-
Adis Summary of Research: Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
Authors
- Julia Paik
- Content type: Adis Summary of Research
- Published: 25 April 2023
- Drugs & Therapy Perspectives
- Pages: 165 - 166